| CEO Name | Cedric Francois |
| Nationality | Belgium |
| Net Worth Estimation | $50 million |
Cedric Francois, CEO of Apellis Pharmaceuticals, has an estimated net worth of around $50 million primarily due to his equity holdings in Apellis, with additional income from executive compensation and stock option grants. His net worth reflects Apellis' market performance and his long-standing leadership role since co-founding the company.
Cedric Francois, CEO of Apellis Pharmaceuticals in the biotechnology sector, has an estimated net worth of $50,000,000. His net worth falls exactly in the midpoint of the provided range, representing 62.5% between the $10,000,000 minimum and $80,000,000 maximum estimations.
Business Category: Biotechnology
Minimum Net Worth (estimation): 10000000 USD
Maximum Net Worth (estimation): 80000000 USD
Cedric Francois Performance in Apellis Pharmaceuticals
Cedric Francois, CEO of Apellis Pharmaceuticals, demonstrates strong leadership through strategic decision-making that drives innovation in complement therapeutics. His performance is marked by successful product developments and partnerships, significantly enhancing the company's market position and pipeline. Under his guidance, Apellis has accelerated growth and expanded its impact in rare disease treatment.
Latest News
Apellis Pharmaceuticals Enhances Leadership and Advances Therapeutics Under CEO Cedric Francois
Apellis Pharmaceuticals, led by CEO Cedric Francois, recently appointed Craig Wheeler, a seasoned biotech executive, to their Board of Directors to strengthen strategic leadership. The company reported strong revenue growth in 2024 and continues to expand its pipeline, including preparing for new drug applications and advancing Phase 3 clinical trials for treatments targeting rare kidney diseases and geographic atrophy. CEO Francois has also actively managed company stock holdings amid these developments.
Source: http://quiverquant.com/news/Apellis+Pharmaceuticals+Appoints+Craig+Wheeler+to+Board+of+Directors